Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001169232-07-002693
Filing Date
2007-06-18
Accepted
2007-06-18 18:31:59
Documents
1
Period of Report
2007-06-14

Document Format Files

Seq Description Document Type Size
1 d07-72186_ex.html 4  
1 d07-72186_ex.xml 4 14042
  Complete submission text file 0001169232-07-002693.txt   15817
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 301-795-1800
Keese Kyle (Reporting) CIK: 0001380186 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 07926914